Aytekin Oğuz
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
- Diabetes Management and Research
- Nephrology top 10%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 19
- Diabetes Management and Research 15
- Diabetes Treatment and Management 11
- Diabetes Management and Education 6
- Co-authors
- Mehmet UzunluluÖzge Telci ÇaklılıÖmer KozanAdnan AbacıÇetin ErolŞükrü ÇelikAhmet TemizhanZeki Öngen
- Journals
- Metabolic Syndrome and Related Disorders (3 papers)Neurology (2 papers)Atherosclerosis Supplements (2 papers)Diabetes & Metabolic Syndrome Clinical Research & Reviews (2 papers)Diabetes & Metabolism (1 paper)
- Partner nations
- TürkiyeUnited KingdomUnited States
In The Last Decade
Aytekin Oğuz
82 papers receiving 913 citations
Peers
Comparison fields: 5 of 102
- Endocrinology, Diabetes and Metabolism 316
- Nephrology 78
- Geriatrics and Gerontology 37
- Cardiology and Cardiovascular Medicine 166
- Epidemiology 217
Countries citing papers authored by Aytekin Oğuz
This map shows the geographic impact of Aytekin Oğuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aytekin Oğuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aytekin Oğuz more than expected).
Fields of papers citing papers by Aytekin Oğuz
This network shows the impact of papers produced by Aytekin Oğuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aytekin Oğuz. The network helps show where Aytekin Oğuz may publish in the future.
Co-authors
The 25 scholars most cited alongside Aytekin Oğuz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 31 | |
| 9 | 2021 | 15 | |
| 10 | 2021 | 3 | |
| 11 | 2018 | 13 | |
| 12 | Levels of pentraxin 3 and relationship with disease activity in patients with ankylosing spondylitis. | 2016 | 13 |
| 13 | Frequency of ABO/Rhesus Blood Groups in Patients with Diabetes Mellitus. | 2016 | 10 |
| 14 | 2012 | 0 | |
| 15 | 2011 | 9 | |
| 16 | 2011 | 1 | |
| 17 | 2010 | 8 | |
| 18 | Glycemic Control of Turkish Adult Diabetic Patients | 2008 | 4 |
| 19 | Frequency of abdominal obesity and metabolic syndrome in healthcare workers and their awareness levels about these entities. | 2008 | 15 |
| 20 | 2005 | 2 |
About Aytekin Oğuz
Aytekin Oğuz is a scholar working on Endocrinology, Diabetes and Metabolism, Research and Theory, Cardiology and Cardiovascular Medicine, Health Informatics and Nephrology, having authored 86 papers that have together received 958 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Diabetes Management and Research (15 papers), Diabetes Treatment and Management (11 papers), Lipoproteins and Cardiovascular Health (7 papers), Nutrition and Health in Aging (7 papers), Nutritional Studies and Diet (7 papers), Diabetes Management and Education (6 papers) and Cardiovascular Function and Risk Factors (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (316 citations), Nephrology (78 citations), Geriatrics and Gerontology (37 citations), Cardiology and Cardiovascular Medicine (166 citations) and Epidemiology (217 citations). Aytekin Oğuz has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Mehmet Uzunlulu, Özge Telci Çaklılı, Ömer Kozan, Adnan Abacı, Çetin Erol, Şükrü Çelik, Ahmet Temizhan, Zeki Öngen, Banu Mesçi and Burcu Doğan. Their work appears in journals such as Metabolic Syndrome and Related Disorders, Neurology, Atherosclerosis Supplements, Diabetes & Metabolic Syndrome Clinical Research & Reviews and Diabetes & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.